U.S. Actinium, Albemarle, ArcBest
Aug 6 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Actinium Pharmaceuticals, Albemarle and ArcBest, on Tuesday.
HIGHLIGHTS
* Actinium Pharmaceuticals Inc ATNM.A: JonesTrading cuts PT to $9 from $26 |
* Albemarle ALB.N: Baird cuts to neutral; cuts target price to $85 from $102 |
* ArcBest Corp ARCB.O: Stephens cuts target price to $130 from $145 |
* Crispr Therapeutics AG CRSP.O: Leerink Partners cuts target price to $68 from $80 |
* Warrior Met Coal Inc HCC.N: Jefferies cuts target price to $78 from $85 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* 89Bio Inc ETNB.O: Raymond James raises target price to $53 from $50 |
* 89Bio Inc ETNB.O: RBC cuts target price to $12 from $13 |
* Actinium Pharmaceuticals Inc ATNM.A: H.C. Wainwright adjusts PT to $4 from $50 |
* Actinium Pharmaceuticals Inc ATNM.A: JonesTrading cuts PT to $9 from $26 |
* Actinium Pharmaceuticals Inc ATNM.A: Maxim Group cuts PT to $5 from $30 |
* Acushnet Holdings Corp GOLF.N: JP Morgan raises target price to $69 from $63 |
* Addus Homecare Corp ADUS.O: Jefferies raises target price to $140 from $130 |
* AES Corp AES.N: RBC cuts target price to $20 from $22 |
* AIG AIG.N: Jefferies cuts target price to $84 from $90 |
* Akoya Biosciences Inc AKYA.O: BTIG cuts to neutral from buy |
* Akoya Biosciences Inc AKYA.O: Craig-Hallum cuts target price to $7 from $7.50 |
* Akoya Biosciences Inc AKYA.O: JP Morgan cuts to neutral from overweight |
* Albemarle ALB.N: Baird cuts to neutral; cuts target price to $85 from $102 |
* Albemarle ALB.N: Berenberg cuts target price to $81 from $83 |
* Albemarle ALB.N: RBC cuts target price to $111 from $128 |
* Albemarle ALB.N: Scotiabank cuts target price to $85 from $135 |
* Alexander's Inc ALX.N: Piper Sandler cuts target price to $125 from $135 |
* Alignment Healthcare Inc ALHC.O: Piper Sandler raises PT to $10 from $8 |
* Alignment Healthcare Inc ALHC.O: TD Cowen raises target price to $10 from $8 |
* Alliant Energy Corp LNT.O: BMO raises target price to $60 from $58 |
* Allstate Corp ALL.N: Jefferies raises target price to $217 from $210 |
* Amazon.Com Inc AMZN.O: Morgan Stanley cuts target price to $210 |
* Ameren Corp AEE.N: BMO raises target price to $87 from $84 |
* Ameresco Inc AMRC.N: Piper Sandler cuts target price to $35 from $37 |
* American Electric Power Company AEP.O: BofA Global Research cuts to to underperform from neutral |
* American Electric Power Company AEP.O: BofA Global Research raises PT to $97 from $96 |
* American Electric Power Company AEP.O: RBC raises PT to $106 from $100 |
* American Healthcare REIT Inc AHR.N: Colliers raises target price to $16 |
* American Well Corporation AMWL.N: Wells Fargo cuts target price to $15 from $40 |
* Anaptysbio Inc ANAB.O: Guggenheim raises target price to $75 from $44 |
* Anaptysbio Inc ANAB.O: Wedbush raises target price to $42 from $34 |
* APA Corp (US) APA.O: UBS cuts target price to $35 from $38 |
* Apollo APO.N: BofA Global Research raises to buy from neutral; cuts PT $123 from $124 |
* Aqua Metals Inc AQMS.O: Benchmark cuts target price to $1 from $2 |
* Aqua Metals Inc AQMS.O: H.C. Wainwright cuts target price to $2 from $4 |
* ArcBest Corp ARCB.O: Stephens cuts target price to $130 from $145 |
* Arcbest Corp ARCB.O: Stifel cuts target price to $131 from $150 |
* Arch Resources Inc ARCH.N: Jefferies cuts target price to $170 from $185 |
* Aspen Aerogels Inc ASPN.N: Barclays initiates coverage with overweight rating; PT $27 |
* ATI Physical Therapy Inc ATIP.N: Jefferies raises target price to $5.50 from $5.30 |
* Atmus Filtration Technologies ATMU.N: Northland Capital raises PT to $38 from $36 |
* Autonation AN.N: JP Morgan raises target price to $160 from $155 |
* Axsome Therapeutics Inc AXSM.O: BofA Global Research raises PT to $106 from $95 |
* Axsome Therapeutics Inc AXSM.O: BofA Global Research raises to buy from neutral |
* Axsome Therapeutics Inc AXSM.O: H.C. Wainwright cuts target price to $180 from $190 |
* Axsome Therapeutics Inc AXSM.O: RBC cuts target price to $130 from $131 |
* Axsome Therapeutics Inc AXSM.O: UBS cuts target price to $105 from $107 |
* Ball Corp BALL.N: UBS raises target price to $59 from $56 |
* Bank of America BAC.N: Oppenheimer cuts target price to $48 from $49 |
* Bank of New York Mellon Corp BK.N: JP Morgan raises PT to $69 from $67 |
* Baxter International Inc BAX.N: Evercore ISI raises target price to $46 from $45 |
* Biocryst Pharmaceuticals Inc BCRX.O: Barclays raises target price to $7 from $6 |
* Biocryst Pharmaceuticals Inc BCRX.O: Jefferies raises target price to $11 from $10 |
* Biocryst Pharmaceuticals Inc BCRX.O: Needham raises target price to $14 from $12 |
* Biogen BIIB.O: Canaccord Genuity cuts target price to $298 from $308 |
* Biogen BIIB.O: Mizuho cuts target price to $251 from $277 |
* Biomarin Pharmaceutical Inc BMRN.O: Barclays cuts target price to $110 from $111 |
* Biomarin Pharmaceutical Inc BMRN.O: Citigroup raises target price to $93 from $91 |
* Biomarin Pharmaceutical Inc BMRN.O: Evercore ISI raises PT to $115 from $113 |
* Biomarin Pharmaceutical Inc BMRN.O: Scotiabank raises target price to $86 from $85 |
* Biomarin Pharmaceutical Inc BMRN.O: Stifel raises target price to $112 from $108 |
* Biomarin Pharmaceutical Inc BMRN.O: TD Cowen cuts PT to $120 from $125 |
* Bioventus Inc BVS.O: Craig-Hallum raises target price to $12 from $9 |
* Black Hills Corp BKH.N: RBC raises target price to $61 from $57 |
* Block Inc SQ.N: Mizuho cuts target price to $94 from $106 |
* Brookfield Corp BN.N: TD Cowen raises target price to $62 from $61 |
* BWX Technologies BWXT.N: Deutsche Bank raises target price to $113 from $112 |
* Cable One Inc CABO.N: JP Morgan raises target price to $480 from $470 |
* Cabot Corp CBT.N: Mizuho cuts target price to $103 from $109 |
* Cabot Corp CBT.N: UBS cuts target price to $98 from $103 |
* Cadence Design Systems CDNS.O: Piper Sandler raises to overweight from neutral |
* California Water Service Group CWT.N: Baird raises target price to $61 from $55 |
* Caretrust REIT Inc CTRE.N: Jefferies raises target price to $31 from $29 |
* Carlyle Group Inc CG.O: Deutsche Bank raises target price to $55 from $52 |
* Carlyle Group Inc CG.O: JP Morgan cuts target price to $44 from $46 |
* Carlyle Group Inc CG.O: JP Morgan cuts to neutral from overweight |
* Carlyle Group Inc CG.O: KBW cuts target price to $46 from $48 |
* Carlyle Group Inc CG.O: Oppenheimer cuts target price to $64 from $69 |
* Carlyle Group Inc CG.O: TD Cowen raises target price to $42 from $41 |
* Carlyle Secured Lending Inc CGBD.O: JP Morgan cuts target price to $16 from $17 |
* Carlyle Secured Lending Inc CGBD.O: Wells Fargo cuts target price to $16 from $17 |
* Cartesian Therapeutics Inc RNAC.O: TD Cowen initiates coverage with buy rating |
* Castle Biosciences Inc CSTL.O: BTIG raises target price to $35 from $32 |
* Castle Biosciences Inc CSTL.O: Leerink Partners raises target price to $45 from $40 |
* Celanese Corp CE.N: Barclays cuts target price to $151 from $170 |
* Celanese Corp CE.N: Jefferies cuts target price to $140 from $155 |
* Celsius Holdings Inc CELH.O: CFRA cuts target price by $10 to $55 |
* Celsius Holdings Inc CELH.O: CFRA raises to buy from hold |
* Centerpoint Energy CNP.N: RBC cuts target price to $31 from $32 |
* Chart Industries Inc GTLS.N: Barclays cuts target price to $147 from $193 |
* Chart Industries Inc GTLS.N: Wells Fargo cuts target price to $151 from $179 |
* Cheesecake Factory Inc CAKE.O: JP Morgan cuts target price to $38 from $40 |
* Chegg Inc CHGG.N: Craig-Hallum cuts target price to $3 from $7 |
* Chegg Inc CHGG.N: Jefferies cuts target price to $2 from $2.5 |
* Chegg Inc CHGG.N: Morgan Stanley cuts target price to $3 from $3.25 |
* Chegg Inc CHGG.N: Piper Sandler cuts target price to $2 from $6 |
* Chemours CC.N: Barclays cuts target price to $22 from $30 |
* Chemours CC.N: BMO cuts target price to $30 from $35 |
* Chemours CC.N: JP Morgan cuts target price to $18 from $25 |
* Chemours Co CC.N: UBS cuts target price to $28 from $30 |
* Chevron Corp CVX.N: Barclays cuts target price to $185 from $203 |
* Chevron Corp CVX.N: HSBC cuts target price to $169 from $178 |
* Church & Dwight Co Inc CHD.N: Barclays raises target price to $82 from $80 |
* Citigroup Inc C.N: Oppenheimer raises target price to $87 from $86 |
* Clearway Energy Inc CWENa.N: Evercore ISI raises target price to $33 from $30 |
* Clene CLNN.O: H.C. Wainwright adjusts PT to $31 from $7 to reflect 1-for-20 reverse stock split |
* Clover Health Investments Corp CLOV.O: Canaccord Genuity raises PT to $2.50 from $2 |
* Clover Health Investments Corp CLOV.O: Leerink Partners raises PT to $2 from $1 |
* Cognition Therapeutics CGTX.O: B. Riley cuts to neutral from buy; cuts PT to $1 from $5 |
* Conocophillips COP.N: UBS cuts target price to $151 from $159 |
* Crispr Therapeutics AG CRSP.O: Chardan Capital Markets cuts PT to $94 from $112 |
* Crispr Therapeutics AG CRSP.O: Leerink Partners cuts target price to $68 from $80 |
* Crowdstrike CRWD.O: Piper Sandler cuts target price to $290 from $310 |
* Crowdstrike CRWD.O: Piper Sandler raises to overweight from neutral |
* CSX Corp CSX.O: Bernstein raises target price to $37 from $36 |
* CSX Corp CSX.O: JP Morgan raises target price to $42 from $39 |
* Day One Biopharmaceuticals Inc DAWN.O: JP Morgan cuts target price to $36 from $38 |
* Definitive Healthcare DH.O: Morgan Stanley cuts target price to $5 from $9 |
* Delcath Systems Inc DCTH.O: BTIG raises target price to $20 from $16 |
* Design Therapeutics Inc DSGN.O: Leerink Partners raises target price to $5 from $4 |
* Dexcom Inc DXCM.O: Baird raises target price to $82 from $80 |
* Diamondback Energy Inc FANG.O: Mizuho raises target price to $229 from $226 |
* Digitalbridge Group Inc DBRG.N: Wells Fargo cuts target price to $18 from $20 |
* Dominion Energy D.N: RBC raises target price to $56 from $53 |
* Doordash DASH.O: Citigroup raises target price to $155 from $144 |
* Dynatrace Inc DT.N: Wells Fargo cuts target price to $50 from $60 |
* Easterly Government Properties Inc DEA.N: Jefferies raises PT to $13 from $12 |
* Eastern Bankshares EBC.O: JP Morgan resumes coverage with neutral rating; PT $18.5 |
* EBay EBAY.O: Truist Securities raises target price to $58 from $50 |
* Enanta Pharmaceuticals Inc ENTA.O: JP Morgan cuts target price to $10 from $11 |
* Encompass Health EHC.N: Barclays cuts target price to $109 from $113 |
* Energy Fuels Inc UUUU.A: H.C. Wainwright cuts target price to $10.50 from $10.75 |
* Entergy ETR.N: BofA Global Research raises price objective to $135 from $116 |
* Entergy ETR.N: RBC raises target price to $124 from $117 |
* Everquote Inc EVER.O: Canaccord Genuity raises target price to $35 from $30 |
* Everquote Inc EVER.O: Craig-Hallum raises target price to $33 from $30 |
* Everquote Inc EVER.O: JP Morgan raises target price to $34 from $29 |
* Everquote Inc EVER.O: Needham raises target price to $38 from $30 |
* Evgo Inc EVGO.O: Stifel cuts target price to $6 from $7 |
* Exxon Mobil XOM.N: Gerdes Energy Research raises target price by $4 to $130 |
* Exxon Mobil XOM.N: HSBC raises target price to $122.5 from $120 |
* Exxon Mobil XOM.N: TD Cowen cuts target price to $130 from $135 |
* Fair Isaac Corp FICO.N: Barclays raises target price to $1,800 from $1,500 |
* FirstEnergy FE.N: RBC raises target price to $46 from $43 |
* Fluor Corp FLR.N: UBS raises target price to $51 from $49 |
* Freshpet Inc FRPT.O: D.A. Davidson raises target price to $175 from $157 |
* Freshpet Inc FRPT.O: Jefferies raises target price to $123 from $118 |
* Freshpet Inc FRPT.O: JP Morgan raises target price to $126 from $113 |
* Fuelcell Energy Inc FCEL.O: UBS cuts target price to $0.5 from $1.35 |
* Gaming and Leisure Properties Inc GLPI.O: Wedbush raises target price to $54 from $51 |
* GE Healthcare GEHC.O: Stifel initiates coverage With Buy rating; target price $100 |
* Goldman Sachs Group GS.N: Oppenheimer cuts target price to $548 from $559 |
* Green Brick Partners Inc GRBK.N: Wedbush raises target price to $60 from $53 |
* Green Thumb Industries Inc GTII.CD: Ventum Financial raises PT to C$24 from C$23 |
* Group 1 Automotive Inc GPI.N: JP Morgan raises target price to $360 from $310 |
* Halozyme Therapeutics Inc HALO.O: JP Morgan cuts target price to $52 from $53 |
* Healthcare Realty Trust Inc HR.N: Jefferies raises target price to $20 from $19 |
* Hims & Hers Health Inc HIMS.N: BofA Global Research cuts PT to $24 from $26 |
* Hims & Hers Health Inc HIMS.N: Guggenheim raises target price to $30 from $20 |
* Hims & Hers Health Inc HIMS.N: Leerink Partners cuts target price to $21 from $25 |
* Honest Company Inc HNST.O: Northland Capital initiates coverage with target price $6 |
* Honest Company Inc HNST.O: Northland Capital initiates coverage with outperform rating |
* Horace Mann Educators HMN.N: Raymond James assumes coverage with strong buy rating |
* Horace Mann Educators HMN.N: Raymond James assumes coverage with target price $42 |
* Host Hotels & Resorts Inc HST.O: Baird cuts target price to $19 from $21 |
* Host Hotels & Resorts Inc HST.O: HSBC cuts target price to $21 from $23 |
* Hub Group Inc HUBG.O: Stifel cuts target price to $43 from $45 |
* Huntsman Corp HUN.N: Mizuho cuts target price to $23 from $24 |
* Huntsman Corp HUN.N: UBS cuts target price to $22 from $23 |
* Independence Realty Trust Inc IRT.N: Colliers raises target price to $21 |
* Infinera Corp INFN.O: JP Morgan raises target price to $6 from $5 |
* Installed Building Products Inc IBP.N: JP Morgan raises PT to $236 from $227 |
* Itron Inc ITRI.O: Guggenheim cuts target price to $128 from $130 |
* JBG Smith Properties JBGS.N: Evercore ISI raises target price to $16 from $15 |
* Jefferies Financial Group Inc JEF.N: Oppenheimer raises target price to $64 from $58 |
* Kellanova K.N: Deutsche Bank raises target price to $76 from $62 |
* Kellanova K.N: Jefferies raises target price to $76 from $62 |
* Kellanova K.N: Wells Fargo raises target price to $76 from $62 |
* Kemper Corp KMPR.N: Piper Sandler raises target price to $80 from $77 |
* Krystal Biotech Inc KRYS.O: Citigroup cuts to neutral from buy |
* Krystal Biotech Inc KRYS.O: Citigroup raises target price to $204 from $195 |
* Krystal Biotech Inc KRYS.O: Guggenheim raises target price to $200 from $175 |
* Leslie'S Inc LESL.O: Mizuho cuts target price to $4 from $6 |
* Lithia Motors Inc LAD.N: JP Morgan raises target price to $315 from $280 |
* LPL Financial Holdings Inc LPLA.O: UBS cuts target price to $215 from $290 |
* Lumen Technologies LUMN.N: Citigroup raises target price to $3.15 from $1.25 |
* Lumen Technologies LUMN.N: Citigroup raises to neutral from sell |
* Magna International Inc MGA.N: CIBC cuts target price to $47 from $50 |
* Magna International Inc MGA.N: JP Morgan cuts target price to $55 from $63 |
* Marriott International Inc MAR.O: Morgan Stanley cuts PT to $250 from $268 |
* Marriott International Inc MAR.O: Morgan Stanley cuts PT to $250.00 from $268.00 |
* Marriott Vacations Worldwide VAC.N: Deutsche Bank cuts target price to $95 from $121 |
* Match Group MTCH.O: HSBC raises target price to $43.20 from $34.10 |
* Match Group MTCH.O: HSBC raises to buy from hold |
* Medifast Inc MED.N: D.A. Davidson cuts target price to $16.50 from $17.50 |
* Mesa Laboratories Inc MLAB.O: Evercore ISI raises target price to $120 from $106 |
* Midcap Financial Investment MFIC.O: KBW raises to outperform from market perform |
* Middlesex Water Co MSEX.O: Baird cuts to neutral from outperform |
* Molson Coors Beverage Co TAP.N: CFRA cuts target price to $65 from $75 |
* Mondelez MDLZ.O: Berenberg cuts target price to $85 from $87 |
* Moog Inc MOGa.N: Morgan Stanley raises target price to $192 from $188 |
* Motorola Solutions MSI.N: Deutsche Bank raises target price to $440 from $385 |
* MP Materials Corp MP.N: D.A. Davidson cuts target price to $20 from $24 |
* MP Materials Corp MP.N: Deutsche Bank cuts target price to $12.5 from $13.5 |
* National Storage Affiliates Trust NSA.N: Evercore ISI cuts PT to $38 from $40 |
* Navitas Semiconductor NVTS.O: Craig-Hallum cuts target price to $6.50 from $7.50 |
* Navitas Semiconductor NVTS.O: Deutsche Bank cuts target price to $6 from $7 |
* Navitas Semiconductor NVTS.O: Morgan Stanley cuts PT to $3.50 from $4.60 |
* Navitas Semiconductor NVTS.O: Needham cuts target price to $5 from $7 |
* Neogen Corp NEOG.O: Piper Sandler raises target price to $17.50 from $17 |
* Neurocrine Biosciences Inc NBIX.O: Canaccord Genuity raises PT to $167 from $164 |
* NNN REIT Inc NNN.N: Colliers raises target price to $50 |
* Northern Trust Corp NTRS.O: JP Morgan cuts target price to $90.50 from $92.50 |
* Northwestern Energy Group Inc NWE.O: Barclays raises target price to $53 from $50 |
* Norwegian Cruise Line NCLH.N: JP Morgan raises target price to $23 from $22 |
* Omega Healthcare Investors Inc OHI.N: Jefferies raises target price to $34 from $30 |
* Omnicell Inc OMCL.O: Piper Sandler raises target price to $61 from $40 |
* Onemain Holdings Inc OMF.N: RBC cuts target price to $60 from $61 |
* Onity Group Inc ONIT.N: KBW raises target price to $35 from $33 |
* Opendoor Technologies Inc OPEN.O: Deutsche Bank cuts target price to $1.85 from $2.4 |
* Pactiv Evergreen Inc PTVE.O: Jefferies cuts target price to $15 from $18 |
* Palantir Technologies PLTR.N: HSBC raises target price to $26 from $23 |
* Palantir Technologies Inc PLTR.N: BofA Global Research raises PT to $30 from $28 |
* Palantir Technologies Inc PLTR.N: D.A. Davidson raises target price to $28 from $24 |
* Palantir Technologies Inc PLTR.N: Deutsche Bank raises target price to $21 from $20 |
* Palantir Technologies Inc PLTR.N: Mizuho raises target price to $24 from $22 |
* Palantir Technologies Inc PLTR.N: Raymond James raises target price to $30 from $25 |
* Palantir Technologies Inc PLTR.N: Wedbush raises target price to $38 from $35 |
* Palomar Holdings Inc PLMR.O: Evercore ISI raises target price to $99 from $90 |
* Park Hotels & Resorts Inc PK.N: HSBC cuts target price to $15 from $18 |
* PayPal PYPL.O: Bernstein cuts target price to $75 from $78 |
* Peabody Energy Corp BTU.N: Jefferies cuts target price to $27 from $28 |
* Penske Automotive Group Inc PAG.N: JP Morgan raises target price to $140 from $135 |
* Pinnacle West Capital Corp PNW.N: RBC raises target price to $81 from $80 |
* Playstudios Inc MYPS.O: Benchmark cuts to hold rating |
* Playstudios Inc MYPS.O: Craig-Hallum cuts target price to $2 from $4 |
* Playstudios Inc MYPS.O: Craig-Hallum cuts to hold from buy |
* Post Holdings Inc POST.N: Barclays raises target price to $125 from $120 |
* Post Holdings Inc POST.N: JP Morgan raises target price to $125 from $118 |
* PPL Corp PPL.N: RBC raises target price to $33 from $31 |
* Privia Health Group Inc PRVA.O: Stephens cuts target price to $24 from $27 |
* Purple Innovation Inc PRPL.O: Craig-Hallum cuts target price to $1.50 from $2 |
* Purple Innovation Inc PRPL.O: Wedbush cuts target price to $1.75 from $2.25 |
* RB Global Inc RBA.N: National Bank of Canada raises target price to $90 from $87 |
* Realty Income Corp O.N: Morgan Stanley resumes coverage with equal-weight rating |
* Realty Income Corp O.N: Morgan Stanley resumes coverage with target price $62 |
* Realty Income Corp O.N: Stifel raises target price to $67.50 from $65 |
* RingCentral RNG.N: Deutsche Bank raises target price to $45 from $42 |
* Rocket Companies Inc RKT.N: Piper Sandler raises target price to $16 from $13 |
* Rocket Pharmaceuticals Inc RCKT.O: Canaccord Genuity cuts PT to $38 from $40 |
* Rocket Pharmaceuticals Inc RCKT.O: JP Morgan raises target price to $54 from $50 |
* Rxsight Inc RXST.O: BTIG cuts target price to $59 from $73 |
* Rxsight Inc RXST.O: JP Morgan cuts target price to $62 from $75 |
* Rxsight Inc RXST.O: Needham cuts target price to $54 from $75 |
* Rxsight Inc RXST.O: Oppenheimer cuts target price to $65 from $72 |
* Rxsight Inc RXST.O: Stifel cuts target price to $65 from $70 |
* Rxsight Inc RXST.O: Wells Fargo cuts target price to $54 from $68 |
* Sage Therapeutics Inc SAGE.O: Canaccord Genuity cuts target price to $9 from $17 |
* Sage Therapeutics Inc SAGE.O: JP Morgan cuts target price to $10 from $12 |
* Schneider National Inc SNDR.N: Stephens raises target price to $26 from $24 |
* SI-Bone Inc SIBN.O: Jefferies cuts target price to $28 from $30 |
* SI-Bone Inc SIBN.O: Morgan Stanley cuts target price to $19 from $21 |
* SI-Bone Inc SIBN.O: Needham cuts target price to $19 from $27 |
* SI-Bone Inc SIBN.O: Truist Securities cuts target price to $18 from $20 |
* Silicon Motion Technology Corp SIMO.O: JP Morgan cuts target price to $82 from $90 |
* Simon Property Group Inc SPG.N: Evercore ISI raises target price to $155 from $150 |
* Simon Property Group Inc SPG.N: Stifel raises target price to $157.50 from $152 |
* Sirius XM Holdings Inc SIRI.O: Deutsche Bank cuts target price to $3 from $3.75 |
* Six Flags Entertainment FUN.N: JP Morgan initiates coverage with target price $50 |
* Six Flags Entertainment FUN.N: JP Morgan initiates coverage with underweight rating |
* SL Green Realty Corp SLG.N: JP Morgan raises target price to $51 from $44 |
* Sonic Automotive Inc SAH.N: JP Morgan raises target price to $63 from $58 |
* Sonic Automotive Inc SAH.N: JP Morgan raises to overweight from neutral |
* Sotera Health Co SHC.O: Barclays raises target price to $17 from $14 |
* Sotera Health Co SHC.O: JP Morgan raises target price to $14 from $12 |
* Sotera Health Co SHC.O: Piper Sandler raises target price to $15 from $13 |
* Southern Co SO.N: RBC raises target price to $88 from $84 |
* Spero Therapeutics Inc SPRO.O: TD Cowen raises to buy from hold |
* SSR Mining Inc SSRM.TO: National Bank of Canada cuts PT to C$7.75 from C$8.75 |
* State Street Corp STT.N: JP Morgan raises target price to $80.50 from $79.50 |
* Sunnova Energy International Inc. NOVA.N: Wells Fargo raises PT to $9 from $6 |
* Syndax Pharmaceuticals Inc SNDX.O: JP Morgan cuts target price to $33 from $34 |
* Tactile Systems Technology Inc TCMD.O: BTIG cuts target price to $16 from $17 |
* Targa Resources Corp TRGP.N: Citigroup raises target price to $150 from $148 |
* Taskus Inc TASK.O: Guggenheim raises target price to $16 from $14 |
* Teladoc Health Inc TDOC.N: Piper Sandler cuts target price to $10 from $25 |
* Telus International TIXT.N: CIBC cuts target price to $5 from $18.50 |
* Teradata Corp TDC.N: Barclays cuts target price to $30 from $35 |
* Teradata Corp TDC.N: Barclays cuts target price to $30 from $35 |
* Teradata Corp TDC.N: BofA Global Research cuts price objective to $32 from $39 |
* Teradata Corp TDC.N: Evercore ISI cuts target price to $34 from $46 |
* Teradata Corp TDC.N: Guggenheim cuts target price to $50 from $60 |
* Teradata Corp TDC.N: Morgan Stanley cuts target price to $30 from $44 |
* Teradata Corp TDC.N: Northland Capital cuts target price to $38 |
* Teradata Corp TDC.N: RBC cuts target price to $32 from $40 |
* Teradata Corp TDC.N: TD Cowen cuts target price to $29 from $37 |
* The Carlyle Group Inc CG.O: Barclays cuts target price to $46 from $51 |
* Thoughtworks Holding Inc TWKS.O: JP Morgan cuts to neutral from overweight |
* Thredup Inc TDUP.O: Wedbush cuts target price to $2 from $3 |
* Thredup Inc TDUP.O: Wells Fargo cuts target price to $3 from $5 |
* TKO Group TKO.N: Moffettnathanson raises target price by $14 to $112 |
* Treehouse Foods THS.N: Barclays raises target price to $39 from $36 |
* Treehouse Foods THS.N: Stifel raises target price to $41 from $36 |
* Tronox Holdings Plc TROX.N: Barclays cuts target price to $19 from $22 |
* TTEC Holdings Inc TTEC.O: Guggenheim cuts target price to $5 from $6 |
* Txnm Energy Inc TXNM.N: Evercore ISI raises target price to $41 from $38 |
* Tyson Foods Inc TSN.N: Barclays raises target price to $72 from $69 |
* Tyson Foods Inc TSN.N: Bernstein raises target price to $73 from $72 |
* Tyson Foods Inc TSN.N: BMO raises target price to $60 from $58 |
* Tyson Foods Inc TSN.N: BofA Global Research raises price objective to $65 from $60 |
* Tyson Foods Inc TSN.N: JP Morgan raises target price to $63 from $61 |
* U.S. Bancorp USB.N: Oppenheimer cuts target price to $54 from $55 |
* Ventas Inc VTR.N: Jefferies raises target price to $66 from $60 |
* Verra Mobility Corp VRRM.O: Morgan Stanley raises target price to $27 from $22 |
* VF Corp VFC.N: TD Cowen raises target price to $16 from $9 |
* Viavi Solutions Inc VIAV.O: Stifel cuts target price to $10.50 from $13 |
* VICI Properties Inc VICI.N: Wedbush raises target price to $33 from $31 |
* Vimeo Inc VMEO.O: Truist Securities raises target price to $7 from $6 |
* Viper Energy Inc VNOM.O: Barclays raises target price to $47 from $44 |
* Warrior Met Coal Inc HCC.N: Jefferies cuts target price to $78 from $85 |
* WEC Energy Group Inc WEC.N: Barclays raises target price to $86 from $80 |
* WEC Energy Group Inc WEC.N: RBC raises target price to $91 from $90 |
* Welltower Inc WELL.N: Jefferies raises target price to $112 from $105 |
* Wesbanco Inc WSBC.O: Stephens raises target price to $34 from $27 |
* Xperi Inc XPER.N: Craig-Hallum cuts target price to $12 from $15 |
* Zoominfo Technologies Inc ZI.O: Barclays cuts target price to $11 from $15 |
* Zoominfo Technologies Inc ZI.O: BofA Global Research cuts PT to $8 from $23 |
* Zoominfo Technologies Inc ZI.O: BofA Global Research cuts to underperform from buy |
* Zoominfo Technologies Inc ZI.O: D.A. Davidson cuts target price to $9.50 from $20 |
* Zoominfo Technologies Inc ZI.O: D.A. Davidson cuts to neutral from buy |
* Zoominfo Technologies Inc ZI.O: Deutsche Bank cuts target price to $12 from $17 |
* Zoominfo Technologies Inc ZI.O: Jefferies cuts target price to $18 from $23 |
* Zoominfo Technologies Inc ZI.O: JP Morgan cuts target price to $14 from $20 |
* Zoominfo Technologies Inc ZI.O: Keybanc cuts to sector weight from overweight |
* Zoominfo Technologies Inc ZI.O: Mizuho cuts target price to $9 from $14 |
* Zoominfo Technologies Inc ZI.O: Morgan Stanley cuts PT to $11.00 from $14.00 |
* Zoominfo Technologies Inc ZI.O: Needham cuts target price to $15 from $25 |
* Zoominfo Technologies Inc ZI.O: Piper Sandler cuts target price to $10 from $14 |
* Zoominfo Technologies Inc ZI.O: Raymond James cuts to market perform from outperform |
* Zoominfo Technologies Inc ZI.O: RBC cuts target price to $7 from $9 |
* Zoominfo Technologies Inc ZI.O: Stifel cuts target price to $13 from $16 |
* Zoominfo Technologies Inc ZI.O: Truist Securities cuts target price to $11 from $16 |
* Zoominfo Technologies Inc ZI.O: Wells Fargo cuts target price to $14 from $19 |
(Compiled by Bengaluru Newsroom)
</body></html>Ähnliche Finanzinstrumente
Neueste News
Rechtlicher Hinweis: Die Unternehmen der XM Group bieten Dienstleistungen ausschließlich zur Ausführung an sowie Zugang zu unserer Online-Handelsplattform. Durch diese können Personen die verfügbaren Inhalte auf oder über die Internetseite betrachten und/oder nutzen. Eine Änderung oder Erweiterung dieser Regelung ist nicht vorgesehen und findet nicht statt. Der Zugang wird stets geregelt durch folgende Vorschriften: (i) Allgemeine Geschäftsbedingungen; (ii) Risikowarnungen und (iii) Vollständiger rechtlicher Hinweis. Die bereitgestellten Inhalte sind somit lediglich als allgemeine Informationen zu verstehen. Bitte beachten Sie, dass die Inhalte auf unserer Online-Handelsplattform keine Aufforderung und kein Angebot zum Abschluss von Transaktionen auf den Finanzmärkten darstellen. Der Handel auf Finanzmärkten birgt ein hohes Risiko für Ihr eingesetztes Kapital.
Sämtliche Materialien, die auf unserer Online-Handelsplattform veröffentlicht sind, dienen ausschließlich dem Zweck der Weiterbildung und Information. Die Materialien beinhalten keine Beratung und Empfehlung im Hinblick auf Finanzen, Anlagesteuer oder Handel und sollten nicht als eine dahingehende Beratung und Empfehlung aufgefasst werden. Zudem enthalten die Materialien keine Aufzeichnungen unserer Handelspreise sowie kein Angebot und keine Aufforderung für jegliche Transaktionen mit Finanzinstrumenten oder unverlangte Werbemaßnahmen für Sie zum Thema Finanzen. Die Materialien sollten auch nicht dahingehend aufgefasst werden.
Alle Inhalte von Dritten und die von XM bereitgestellten Inhalte sowie die auf dieser Internetseite zur Verfügung gestellten Meinungen, Nachrichten, Forschungsergebnisse, Analysen, Kurse, sonstigen Informationen oder Links zu Seiten von Dritten werden ohne Gewähr bereitgestellt. Sie sind als allgemeine Kommentare zum Marktgeschehen zu verstehen und stellen keine Anlageberatung dar. Soweit ein Inhalt als Anlageforschung aufgefasst wird, müssen Sie beachten und akzeptieren, dass der Inhalt nicht in Übereinstimmung mit gesetzlichen Bestimmungen zur Förderung der Unabhängigkeit der Anlageforschung erstellt wurde. Somit ist der Inhalt als Werbemitteilung unter Beachtung der geltenden Gesetze und Vorschriften anzusehen. Bitte stellen Sie sicher, dass Sie unseren Hinweis auf die nicht unabhängige Anlageforschung und die Risikowarnung im Hinblick auf die vorstehenden Informationen gelesen und zur Kenntnis genommen haben, die Sie hier finden.